These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 21068471)
1. Metabolic syndrome: what are the risks for humans? Gupta A; Gupta V Biosci Trends; 2010 Oct; 4(5):204-12. PubMed ID: 21068471 [TBL] [Abstract][Full Text] [Related]
2. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328 [TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome and its cardiovascular manifestations. Sánchez-Torres RJ; Delgado-Osorio H Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A; Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482 [TBL] [Abstract][Full Text] [Related]
5. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240 [TBL] [Abstract][Full Text] [Related]
6. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472 [TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome: definition and therapeutic implications. Prasad H; Ryan DA; Celzo MF; Stapleton D Postgrad Med; 2012 Jan; 124(1):21-30. PubMed ID: 22314111 [TBL] [Abstract][Full Text] [Related]
8. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539 [TBL] [Abstract][Full Text] [Related]
11. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Liu J; Young TK; Zinman B; Harris SB; Connelly PW; Hanley AJ Obesity (Silver Spring); 2006 Mar; 14(3):500-8. PubMed ID: 16648622 [TBL] [Abstract][Full Text] [Related]
12. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults. Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513 [TBL] [Abstract][Full Text] [Related]
13. Use of the metabolic syndrome in pediatrics: a blessing and a curse. Battista M; Murray RD; Daniels SR Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE; Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172 [TBL] [Abstract][Full Text] [Related]
15. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP; Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061 [TBL] [Abstract][Full Text] [Related]
16. The longitudinal effects of physical activity history on metabolic syndrome. Yang X; Telama R; Hirvensalo M; Mattsson N; Viikari JS; Raitakari OT Med Sci Sports Exerc; 2008 Aug; 40(8):1424-31. PubMed ID: 18614950 [TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531 [TBL] [Abstract][Full Text] [Related]
19. Diagnosing metabolic syndrome in type 2 diabetes: does it matter? Song SH; Hardisty CA QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792 [TBL] [Abstract][Full Text] [Related]
20. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]